IP Library Granted Patent US 10,842,852
Granted Patent B2
US 10,842,852 · App. 15/280,502 · Granted Nov 24, 2020

Methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 targeting peptide

Inventors: Alain Prochiantz (Paris, FR); Ariel Di Nardo (Palaiseau, FR); Marine Beurdeley (Paris, FR); Takao Hensch (Newton, MA)
Assignees: Centre National de la Recherche Scientifique; Ecole Normale Superieure
A61K38/465A61K38/1709A61K47/62C07K14/47C07K14/4702C12N9/16C12Y301/03001A61K9/0048A61K35/12A61K35/30A61L27/3604A61L27/383A61L2300/252A61L2300/64A61P25/00A61P25/28A61P27/02A61P43/00C07K2319/00C07K2319/03C07K2319/33C12N5/0602C12N5/0618C12N5/0619C12N5/0621C12N5/16C12N15/85C12N15/907C12N2501/40C12N2501/50C12N2501/58C12N2502/085C12N2506/08C12N2830/008C12Q1/6881G01N33/5005G01N33/5044G01N33/5058G01N33/57496G01N2500/10G01N2800/164G01N2800/168
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,842,852
App. No.
15/280,502
Granted
Nov 24, 2020
Kind
B2
Abstract

The disclosure provides a method of delivering a polypeptide molecule to an Otx2 target cell, including contacting the target cell with a chimeric polypeptide having (i) a targeting peptide consisting of SEQ ID NO: 2 and (ii) the polypeptide molecule.

Claims (13)

1. A method of delivering a polypeptide molecule to an Orthodenticle Homeobox 2 (Otx2) target cell selected from retinal ganglion neurons, retinal bipolar neurons and parvalbumin neurons, comprising

contacting the target cell with a chimeric polypeptide consisting of:

(i) a targeting peptide consisting of the amino acid sequence SEQ ID NO: 2 bonded with

(ii) a heterologous polypeptide molecule which is not an Otx2 protein, wherein the targeting peptide is located at the C-terminus of the chimeric polypeptide.

2. A method of delivering a polypeptide molecule to an Otx2 target cell selected from retinal ganglion neurons, retinal bipolar neurons and parvalbumin neurons in a subject comprising delivering a polypeptide molecule to the target cell according to the method of claim 1 , wherein the delivering comprises administering the polypeptide molecule to the subject by infusion.

3. A method of delivering a polypeptide molecule to an Orthodenticle Homeobox 2 (Otx2) target cell selected from retinal ganglion neurons, retinal bipolar neurons and parvalbumin neurons, comprising

contacting the target cell with a chimeric polypeptide consisting of:

(i) a targeting peptide consisting of the amino acid sequence of SEQ ID NO: 2 bonded with

(ii) a heterologous polypeptide molecule which is not an Otx2 protein, and

(iii) a VP16 trans-activator domain of herpes virus,

wherein the targeting peptide is located at the C-terminus of the chimeric polypeptide.

4. The method according to claim 3 , wherein the VP16 trans-activator domain contains the amino acid sequence of SEQ ID NO: 4.

5. A method of delivering a polypeptide molecule to an Otx2 target cell selected from retinal ganglion neurons, retinal bipolar neurons and parvalbumin neurons in a subject comprising delivering a polypeptide molecule to the target cell according to the method of claim 3 , wherein the delivering comprises administering the polypeptide molecule to the subject by infusion.

Assignments (1)
CONFIRMATORY LICENSE Recorded Aug 2, 2022
From: BOSTON CHILDREN'S HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061044/0382 →
Priority Claims (1)
FR 09 00217 · Jan 19, 2009 · national
Continuity (2)
Division 13145066
Related Publication 20170080060A1 · Mar 23, 2017